Literature DB >> 12363119

The association between substance abuse and antidepressant-induced mania in bipolar disorder: a preliminary study.

Joseph F Goldberg1, Joyce E Whiteside.   

Abstract

BACKGROUND: Estimates of the prevalence and features of antidepressant-induced mania vary widely, with few data available on its potential risk factors.
METHOD: Fifty-three DSM-IV bipolar patients were interviewed to retrospectively identify lifetime affective episodes, pharmacotherapy trials, and clinical outcomes, with corroboration from treating clinicians and reviews of medical, psychiatric, and pharmacy records. Particular attention was given to the possible relationship between antidepressant-induced mania and the presence of psychoactive substance abuse or dependence.
RESULTS: Antidepressant-induced mania or hypomania was evident in 39.6% (21/53) of the study group. Patients who developed manic features soon after starting an antidepressant had more antidepressant trials per year than those who did not (p < .05). A history of substance abuse and/or dependence was associated with substantially increased risk for antidepressant-induced mania (odds ratio = 6.99, 95% CI = 1.57 to 32.28, p = .007). Concomitant mood stabilizers were not uniformly associated with protection against inductions of mania during antidepressant trials.
CONCLUSION: Multiple antidepressant exposures among bipolar patients with histories of substance abuse and/or dependence may be associated with an elevated risk for antidepressant-induced mania.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12363119     DOI: 10.4088/jcp.v63n0907

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  11 in total

1.  A review of bipolar disorder in adults.

Authors:  Donald M Hilty; Martin H Leamon; Russell F Lim; Rosemary H Kelly; Robert E Hales
Journal:  Psychiatry (Edgmont)       Date:  2006-09

Review 2.  Preventative strategies for early-onset bipolar disorder: towards a clinical staging model.

Authors:  Robert K McNamara; Jayasree J Nandagopal; Stephen M Strakowski; Melissa P DelBello
Journal:  CNS Drugs       Date:  2010-12       Impact factor: 5.749

3.  Course of illness following prospectively observed mania or hypomania in individuals presenting with unipolar depression.

Authors:  Jess G Fiedorowicz; Jean Endicott; David A Solomon; Martin B Keller; William H Coryell
Journal:  Bipolar Disord       Date:  2012-07-20       Impact factor: 6.744

4.  Treatment development and feasibility study of family-focused treatment for adolescents with bipolar disorder and comorbid substance use disorders.

Authors:  Benjamin I Goldstein; Tina R Goldstein; Katelyn A Collinger; David A Axelson; Oscar G Bukstein; Boris Birmaher; David J Miklowitz
Journal:  J Psychiatr Pract       Date:  2014-05       Impact factor: 1.325

Review 5.  Pharmacotherapy of alcoholism in patients with co-morbid psychiatric disorders.

Authors:  Benjamin I Goldstein; Artemis Diamantouros; Ayal Schaffer; Claudio A Naranjo
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 6.  The psychopathology and treatment of bipolar disorder.

Authors:  David J Miklowitz; Sheri L Johnson
Journal:  Annu Rev Clin Psychol       Date:  2006       Impact factor: 18.561

7.  Undiagnosed Bipolar Disorder: New Syndromes and New Treatments.

Authors:  Ira D Glick
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2004

8.  Substance use disorders among adolescents with bipolar spectrum disorders.

Authors:  Benjamin I Goldstein; Michael A Strober; Boris Birmaher; David A Axelson; Christianne Esposito-Smythers; Tina R Goldstein; Henrietta Leonard; Jeffrey Hunt; Mary Kay Gill; Satish Iyengar; Colleen Grimm; Mei Yang; Neal D Ryan; Martin B Keller
Journal:  Bipolar Disord       Date:  2008-06       Impact factor: 6.744

Review 9.  Personalized Pharmacotherapy for Bipolar Disorder: How to Tailor Findings From Randomized Trials to Individual Patient-Level Outcomes.

Authors:  Joseph F Goldberg
Journal:  Focus (Am Psychiatr Publ)       Date:  2019-07-16

10.  A case of hypomania during nicotine cessation treatment with bupropion.

Authors:  Karine Giasson-Gariépy; Didier Jutras-Aswad
Journal:  Addict Sci Clin Pract       Date:  2013-12-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.